๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Efficacy of venlafaxine in the treatment of severe depression

โœ Scribed by Allison S. Kienke; Jerrold F. Rosenbaum


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
101 KB
Volume
12
Category
Article
ISSN
1091-4269

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Venlafaxine. Pharmacology and therapeuti
โœ Frances E. Burnett; Timothy G. Dinan ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 158 KB ๐Ÿ‘ 1 views

Venlafaxine is the ยฎrst available antidepressant of the structurally novel SNRI (serotonin noradrenaline-reuptake inhibitor) class of drugs. It resembles the tricyclics in its ability to inhibit presynaptic reuptake of both serotonin and noradrenaline to a clinically signiยฎcant degree. However, it d

Treatment of severe depression with the
โœ Alan F. Schatzberg ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 120 KB ๐Ÿ‘ 1 views

The selective serotonin reuptake inhibitors (SSRIs) are recognized as effective as and better tolerated than older antidepressant therapies and have become the drugs of choice in the treatment of mild to moderate depression. However, there is a clinical impression that the SSRIs are less effective t

The Place of Milnacipran in the Treatmen
โœ S. Kasper ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB ๐Ÿ‘ 2 views

Modern community-based studies have revealed high prevalence rates for major depression in adults. Despite this high prevalence, many depressed individuals do not seek treatment and only a minority of those that do are prescribed antidepressants. This paper considers the role of antidepressants, esp